Toggle light / dark theme

With Utter Self-Seriousness, Maker of Oreos Admits It’s Using AI To Create New Flavors, Even Though Machines Cannot Taste

The company behind Oreo cookies has, by its own admission, been quietly creating new flavors using machine learning.

As the Wall Street Journal reports, Mondelez — the processed food behemoth that manufactures Oreos, Chips Ahoy, Clif Bars, and other popular snacks — has developed a new AI tool to dream up new flavors for its brands.

Used in more than 70 of the company’s products, the company says the machine learning tool is different from generative AI tools like ChatGPT and more akin to the drug discovery algorithms used by pharmaceutical companies to find and test new medications rapidly. Thus far the tool, created with the help of the software consultant Fourkind, has created products like the “Gluten Free Golden Oreo” and updated Chips Ahoy’s classic recipe, per the WSJ.

AI ‘artist’ pulls in millions — and may ‘create more interesting work than humans,’ co-creator says

Domo arigato, Mr. Botto.

The next artistic masterpiece may be more machine than man: An artificial intelligence design program called Botto has sold computerized works for megabucks and could revolutionize the creative space.

Since its creation in 2021, Botto has created more than 150 works of various disciplines that have cumulatively raked in over $5 million at auction, CNBC reported.

Robots In Space: Hayabusa2 at Ryugu asteroid

Journey into one of humanity’s most ambitious space missions as we explore JAXA’s groundbreaking Hayabusa2 mission to asteroid Ryugu! Discover how this remarkable spacecraft not only achieved the first successful deployment of rovers on an asteroid but also brought back precious samples that could reveal secrets about our solar system’s formation. From the dramatic touchdown on Ryugu’s surface to the revolutionary MASCOT and MINERVA rovers that hopped across its microgravity environment, this video breaks down the incredible technology and scientific discoveries from this historic asteroid sample return mission. Learn how these primitive asteroid samples are reshaping our understanding of the early solar system and what this means for future space exploration.

The Art of AI in Drug Discovery

Leveraging the success of this new program, just about two years from its launch DeepMind’s AI spinout Isomorphic announced two drug discovery deals, worth $3 billion each, with Eli Lilly and Novartis.

Earlier this year, microprocessor giant NVIDIA also dove head first into AI for drug discovery, making big investments and deals with leaders like Recursion Pharmaceuticals and Genentech.

AI in drug discovery seems to be having a moment.